{"id":2868,"date":"2023-04-14T16:46:08","date_gmt":"2023-04-14T07:46:08","guid":{"rendered":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/?page_id=2868"},"modified":"2023-04-14T16:46:08","modified_gmt":"2023-04-14T07:46:08","slug":"2018-2","status":"publish","type":"page","link":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/2018-2\/","title":{"rendered":"2018"},"content":{"rendered":"

2018 (\u8ad6\u6587)<\/h2>\n
    \n
  1. Watanabe H, Yoshimura M, Sano K, Shimizu Y, Kaide S, Nakamoto Y, Togashi K, Ono M, Saji H.<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Characterization of Novel 18<\/sup>F-Labeled Phenoxymethylpyridine Derivatives as Amylin Imaging Probes<\/span><\/span><\/span>
    \nMol. Pharm.<\/em>\u00a015(12) 5574-5584 (2018)<\/li>\n
  2. Watanabe H, Saji H, Ono M.<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Novel Fluorescence Probes based on the Chalcone Scaffold for In vitro Staining of \u03b2-Amyloid Plaques<\/span><\/span><\/span>
    \nBioorg. Med. Chem. Lett.<\/em>\u00a028(19) 3242-3246 (2018)<\/li>\n
  3. Sano K, Kanada Y, Takahashi K, Ding N, Kanazaki K, Mukai T, Ono M, Saji H.<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Enhanced Delivery of Radiolabeled Polyoxazoline into Tumors via Self-Aggregation Under Hyperthermic Conditions<\/span><\/span><\/span>
    \nMol. Pharm.<\/em>\u00a015(9) 3997-4003 (2018)<\/li>\n
  4. Kimura H, Yamauchi S, Kawashima H, Arimitsu K, Yagi Y, Nakamoto Y, Togashi K, Ono M, Saji H.
    \n<\/span><\/span><\/span>Synthesis and evaluation of a [18<\/sup>F]formyl-Met-Leu-Phe derivative: A positron emission tomography imaging probe for bacterial infections<\/span><\/span><\/span>
    \nBioorg. Med. Chem. Lett.<\/em> 28(17) 2949-2952 (2018)<\/li>\n
  5. Kaide S, Ono M, Watanabe H, Shimizu Y, Nakamoto Y, Togashi K, Yamaguchi A, Hanaoka H, Saji H.<\/span><\/span><\/span>
    \nConversion of Iodine to Fluorine-18 Based on Iodinated Chalcone and Evaluation for \u03b2-Amyloid PET Imaging<\/span><\/span><\/span>
    \nBioorg. Med. Chem.<\/em>\u00a026(12) 3352-3358 (2018)<\/li>\n
  6. Ikeda H, Ishii A, Sano K, Chihara H, Arai D, Abekura Y, Nishi H, Ono M, Saji H, Miyamoto S.<\/span><\/span><\/span>
    \nActivatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green<\/span><\/span><\/span>
    \nAtherosclerosis<\/span>\u00a0<\/span><\/em>275<\/span>\u00a01-10\u00a0(2018)<\/li>\n
  7. Iikuni S, Ono M, Watanabe H, Shimizu Y, Sano K, Saji H.<\/span><\/span><\/span>
    \nCancer radiotheranostics targeting carbonic anhydrase-IX with 111<\/sup>In- and 90<\/sup>Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy<\/span><\/span><\/span>
    \nTheranostics<\/em><\/span>\u00a08(11) 2992-3006\u00a0(2018)<\/li>\n
  8. Temma T, Kondo N, Yoda K, Nishigori K, Onoe S, Shiomi M, Ono M, Saji H.<\/span><\/span><\/span>
    \nComparison of 125<\/sup>I- and 111<\/sup>In-labeled peptide probes for in vivo detection of oxidized low density lipoprotein in atherosclerotic plaques<\/span><\/span><\/span>
    \nAnn. Nucl. Med.<\/em>\u00a032(6) 410-416 (2018)<\/li>\n
  9. Kaide S, Ono M, Watanabe H, Kitada A, Yoshimura M, Shimizu Y, Ihara M, Saji H.<\/span><\/span>
    \nStructure-Activity Relationships of Radioiodinated Benzoimidazopyridine Derivatives for Detection of Tau Pathology<\/span><\/span>
    \nACS Med. Chem. Lett.<\/em>\u00a09(5) 478-483\u00a0(2018)<\/li>\n
  10. Matsuoka D, Watanabe H, Shimizu Y, Kimura H, Yagi Y, Kawai R, Ono M, Saji H.<\/span><\/span>
    \nStructure\u2013activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen<\/span><\/span>
    \nBioorg. Med. Chem.<\/em>\u00a026(9) 2291-2301\u00a0(2018)<\/li>\n
  11. Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.<\/span><\/span>
    \n18<\/sup>F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer – Biodistribution and radiation dosimetry assessment of first-in-man 18<\/sup>F-FPYBF-2 PET imaging –<\/span><\/span>
    \nAnn. Nucl. Med.<\/em>\u00a032(4) 256-263\u00a0(2018)<\/li>\n
  12. Higashi T, Nishii R, Kagawa S, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.<\/span><\/span>
    \n18<\/sup>F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer\u00a0 \u2013 First experience in 61 volunteers and 55 patients with dementia \u2013<\/span><\/span>
    \nAnn. Nucl. Med.<\/em>\u00a032(3) 206-216 (2018)<\/li>\n
  13. Makino A, Miyazaki A, Tomoike A, Kimura H, Arimitsu K, Hirata M, Ohmomo Y, Nishii R, Okazawa H, Kiyono Y, Ono M, Saji H.<\/span><\/span>
    \nPET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy<\/span><\/span>
    \nBioorg. Med. Chem.<\/em>\u00a026(8) 1609-1613 (2018)<\/li>\n
  14. Kawai R, Araki M, Yoshimura M, Kamiya N, Ono M, Saji H, Okuno Y.<\/span><\/span>
    \nCore Binding Site of a Thioflavin-T-derived Imaging Probe on Amyloid \u03b2 Fibrils Predicted by Computational Methods<\/span><\/span>
    \nACS Chem. Neurosci.<\/em>\u00a09(5) 957-966 (2018)<\/li>\n
  15. Abe J, Isobe N, Mikata K, Nagahori H, Naito Y, Saji H, Ono M, Kawamura S.<\/span><\/span>
    \nFlumioxazin metabolism in pregnant animals and cell-based protoporphyrinogen IX oxidase (PPO) inhibition assay of fetal metabolites in various animal species to elucidate the mechanism of the rat-specific developmental toxicity<\/span><\/span>
    \nToxicol. Appl. Pharmacol.<\/span><\/em> 339 34-41<\/span>(2018)<\/li>\n
  16. Takahashi Y, Araie Y, Nomura D, Takahashi Y, Sano K, Saji H, Takakura Y, Nishikawa M.<\/span><\/span>
    \nConstruction of nanostructured DNA harbouring phosphorodiamidate morpholino oligonucleotide for controlled tissue distribution in mice<\/span><\/span>
    \nJ. Drug. Target.<\/em>\u00a026(4) 373-381 (2018)<\/li>\n
  17. Kimura H, Ogawa Y, Fujimoto H, Mukai E, Kawashima H,\u00a0Arimitsu K, Toyoda K, Fujita N, Yagi Y, Hamamatsu K, Murakami T, Murakami A, Ono M, Nakamoto Y, Togashi K, Inagaki N, Saji H.<\/span><\/span>
    \nEvaluation of 18<\/sup>F-Labeled Exendin(9-39) Derivatives Targeting Glucagon-like Peptide-1 Receptor for Pancreatic \u03b2-cell Imaging<\/span><\/span>
    \nBioorg. Med. Chem.<\/em> 26(2) 463-469 (2018)<\/li>\n<\/ol>\n

    \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n

    2018 (\u8457\u66f8\u7b49)<\/h2>\n
      \n
    1. \u6e21\u908a \u88d5\u4e4b\uff0c\u5c0f\u91ce \u6b63\u535a.<\/span>
      \n<\/span><\/span><\/span><\/span>\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u767a\u75c7\u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u65b0\u898f\u8a3a\u65ad\u6cd5\u30fb\u5275\u85ac\u30fb\u6cbb\u7642\u958b\u767a\u3000(\u7b2c2\u7de8 \u7b2c2\u7ae0 \u7b2c3\u7bc0 \u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u539f\u56e0\u30bf\u30f3\u30d1\u30af\u8cea\u691c\u51fa\u7528\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span>
      \n2018\u5e748\u6708\u767a\u520a (NTS\u793e)<\/li>\n<\/ol>\n

      \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n

      2018 (\u5b66\u4f1a\u767a\u8868)<\/h2>\n
        \n
      1. Hiroyuki Watanabe, Kengo Fukui, Yoichi Shimizu, Hideo Saji, Masahiro Ono<\/span><\/span><\/span>
        \nSynthesis and evaluation of 18<\/sup>F-labeled tetrahydroisoquinoline derivatives as novel PET probes for imaging orexin 1 receptors<\/span><\/span><\/span>
        \nThe 7th Annual IIIS Symposium<\/span> (Tokyo, Japan) December\u00a020, 2018<\/span><\/span><\/span><\/span><\/li>\n
      2. Masahiro Ono<\/span><\/span>
        \nDevelopment of Radiopharmaceuticals for Alzheimer’s Disease (Keynote Lecture)<\/span><\/span><\/span>
        \nThe 10th China-Japan-Korea Symposium on Radiopharmaceutical Sciences (<\/span><\/span><\/span>Xiamen, China) November\u00a02-4, 2018<\/span><\/span><\/span><\/li>\n
      3. Shimpei Iikuni, Hiroyuki Watanabe, Yoichi Shimizu, Hideo Saji, Masahiro Ono<\/span><\/span><\/span>
        \n<\/span>Cancer radiotheranostics targeting carbonic anhydrase-IX with radiometallic chelate based on ureidosulfonamide<\/span><\/span>
        \nThe 10th China-Japan-Korea Symposium on Radiopharmaceutical Sciences (Xiamen, China) November\u00a02-4, 2018<\/span><\/span><\/span><\/span><\/li>\n
      4. \u5ca1\u7530 \u7950\u54c9, \u98ef\u570b \u614e\u5e73, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u963f\u90e8 \u52d9, \u4f50\u6cbb \u82f1\u90ce, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n\u30a4\u30df\u30c0\u30be\u30c1\u30a2\u30b8\u30a2\u30be\u30fc\u30eb\u9aa8\u683c\u3092\u7528\u3044\u305f\u70ad\u9178\u8131\u6c34\u9175\u7d20IX (CA-IX)\u6a19\u7684\u6838\u533b\u5b66\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span>
        \n\u7b2c58<\/span>\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a<\/span>\uff08\u6c96\u7e04\uff092018\u5e7411\u670815\u65e5\u301c17\u65e5<\/span><\/li>\n
      5. \u8c9d\u51fa \u7fd4, \u6e21\u908a \u88d5\u4e4b, \u8fb0\u5df3 \u60a0\u83ef, \u5fd7\u6c34 \u967d\u4e00, \u4f50\u6cbb \u82f1\u90ce, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30d4\u30ea\u30b8\u30f3\u9aa8\u683c\u3092\u57fa\u76e4\u3068\u3059\u308b\u65b0\u898fPET\u7528\u30bf\u30a6\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span>
        \n\u7b2c58<\/span>\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a<\/span>\uff08\u6c96\u7e04\uff092018\u5e7411\u670815\u65e5\u301c17\u65e5<\/span><\/li>\n
      6. \u98ef\u570b \u614e\u5e73, <\/span>\u5c0f\u91ce \u6b63\u535a<\/span>
        \n\u70ad\u9178\u8131\u6c34\u9175\u7d20IX\u3092\u6a19\u7684\u3068\u3057\u305f\u65b0\u898fTheranostics\u7528\u91d1\u5c5e\u30ad\u30ec\u30fc\u30c8\u306b\u3088\u308b\u816b\u760d\u4f4e\u9178\u7d20\u9818\u57df\u306e\u8a3a\u65ad\u304a\u3088\u3073\u6cbb\u7642<\/span><\/span><\/span>
        \n\u7b2c<\/span>77<\/span>\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a<\/span><\/span>\uff08\u5927\u962a\uff092018\u5e749\u670827\u65e5\u301c29\u65e5<\/span><\/li>\n
      7. \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span>
        \n<\/span><\/span>\u8a8d\u77e5\u75c7\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642\u306b\u8cc7\u3059\u308b\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0 (\u62db\u5f85\u8b1b\u6f14)<\/span><\/span><\/span><\/span><\/span>
        \n<\/span><\/span>\u5275\u5264\u30d5\u30a9\u30fc\u30e9\u30e0 \u7b2c24\u56de\u82e5\u624b\u7814\u7a76\u4f1a<\/span><\/span><\/span><\/span><\/span>\uff08\u795e\u6238)\u00a02018\u5e749\u670822\u65e5<\/span><\/span><\/span><\/li>\n
      8. \u98ef\u570b \u614e\u5e73, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u4f50\u6cbb \u82f1\u90ce\uff0c\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n<\/span>\u653e\u5c04\u6027\u91d1\u5c5e\u932f\u4f53\u3092\u7528\u3044\u305f\u70ad\u9178\u8131\u6c34\u9175\u7d20-IX\u9ad8\u767a\u73fe\u816b\u760d\u306b\u5bfe\u3059\u308bRadiotheranostics<\/span><\/span><\/span>
        \n\u7b2c2\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5206\u79d1\u4f1a \u653e\u5c04\u6027\u85ac\u54c1\u79d1\u5b66\u7814\u7a76\u4f1a\/<\/span>\u7b2c<\/span>18<\/span>\u56de\u653e\u5c04\u6027\u533b\u85ac\u54c1\u30fb\u753b\u50cf\u8a3a\u65ad\u85ac\u7814\u7a76\u4f1a<\/span>\uff08\u6771\u4eac\uff09<\/span>2018\u5e749\u67088\u65e5<\/span><\/li>\n
      9. \u8c9d\u51fa \u7fd4, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u4f50\u6cbb \u82f1\u90ce, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n\u30bf\u30a6\u306e\u751f\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305fSPECT\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span>
        \n2018 \u30bf\u30a6\u7814\u7a76\u30df\u30fc\u30c6\u30a3\u30f3\u30b0<\/span>\uff08\u4eac\u90fd\uff092018\u5e749\u67085\u65e5<\/li>\n
      10. \u8c37\u6751 \u572d\u4e00, \u98ef\u570b \u614e\u5e73, \u5fd7\u6c34 \u967d\u4e00, \u6e21\u908a \u88d5\u4e4b, \u4f50\u6cbb \u82f1\u90ce, \u5c0f\u91ce \u6b63\u535a<\/span><\/span>
        \n\u70ad\u9178\u8131\u6c34\u9175\u7d20IX\u306e\u751f\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f99m<\/sup>Tc-\u30d2\u30c9\u30ed\u30ad\u30b5\u30e0\u30a2\u30df\u30c9\u932f\u4f53\u306e\u958b\u767a<\/span><\/span><\/span>
        \n\u7b2c16\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u306e\u305f\u3081\u306e\u30d5\u30a3\u30b8\u30ab\u30eb\u30fb\u30d5\u30a1\u30fc\u30de\u30d5\u30a9\u30fc\u30e9\u30e0\uff08\u795e\u5948\u5ddd\uff092018\u5e749\u67083\u65e5, 4\u65e5<\/li>\n
      11. \u4e09\u6728 \u7950\u5178, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u4f50\u6cbb \u82f1\u90ce, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n\u81b5\u5cf6\u5185\u30a2\u30df\u30ea\u30f3\u306e\u751f\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f2\u5149\u5b50\u52b1\u8d77\u86cd\u5149\u30d7\u30ed\u30fc\u30d6\u306b\u95a2\u3059\u308b\u691c\u8a0e<\/span><\/span><\/span>
        \n\u7b2c16\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u306e\u305f\u3081\u306e\u30d5\u30a3\u30b8\u30ab\u30eb\u30fb\u30d5\u30a1\u30fc\u30de\u30d5\u30a9\u30fc\u30e9\u30e0\uff08\u795e\u5948\u5ddd\uff092018\u5e749\u67083\u65e5, 4\u65e5<\/li>\n
      12. \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span>
        \n<\/span><\/span>\u8a8d\u77e5\u75c7\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642\u306e\u305f\u3081\u306e\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0(\u62db\u5f85\u8b1b\u6f14)<\/span><\/span><\/span><\/span><\/span>
        \n<\/span><\/span>Joint Symposium on Dementia<\/span><\/span><\/span><\/span>\uff08\u4eac\u90fd)\u00a02018\u5e746\u67086\u65e5<\/span><\/span><\/span><\/li>\n
      13. \u677e\u4e0b \u76f4\u6a39, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce<\/span><\/span><\/span><\/span><\/span>
        \n<\/span><\/span><\/span>\u30aa\u30ec\u30ad\u30b7\u30f32\u53d7\u5bb9\u4f53\u306e\u751f\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f18<\/sup>F\u6a19\u8b58\u30b8\u30a2\u30ea\u30eb\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c13\u56de\u65e5\u672c\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a \uff08\u6771\u4eac\uff092018\u5e745\u670831\u65e5, \uff16\u67081\u65e5<\/span><\/span><\/span><\/li>\n
      14. \u6e21\u908a \u88d5\u4e4b, \u4e09\u6728 \u7950\u5178, \u5fd7\u6c34 \u967d\u4e00, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce<\/span>
        \n<\/span><\/span><\/span>\u81b5\u5cf6\u30a2\u30df\u30ea\u30f3\u3092\u6a19\u7684\u3068\u3057\u305f 2 \u5149\u5b50\u52b1\u8d77\u86cd\u5149\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span><\/span>
        \n\u7b2c13\u56de\u65e5\u672c\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a \uff08\u6771\u4eac\uff092018\u5e745\u670831\u65e5, \uff16\u67081\u65e5<\/span><\/span><\/span><\/li>\n
      15. \u98ef\u570b \u614e\u5e73<\/span>, <\/span>\u5c0f\u91ce \u6b63\u535a<\/span>, <\/span>\u6e21\u908a \u88d5\u4e4b<\/span>, <\/span>\u5fd7\u6c34 \u967d\u4e00<\/span>, <\/span>\u4f50\u6cbb \u82f1\u90ce<\/span><\/span><\/span><\/span>
        \n\u70ad\u9178\u8131\u6c34\u9175\u7d20<\/span>-IX<\/span>\u9ad8\u767a\u73fe\u816b\u760d\u306e\u6838\u533b\u5b66\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f<\/span>2<\/span>\u4fa1\u653e\u5c04\u6027\u30ac\u30ea\u30a6\u30e0\u932f\u4f53\u306e\u958b\u767a<\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c138\u5e74\u4f1a \uff08\u91d1\u6ca2)\u00a02018\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      16. \u8c9d\u51fa \u7fd4<\/span>, <\/span>\u5c0f\u91ce \u6b63\u535a<\/span>, <\/span>\u6e21\u908a \u88d5\u4e4b<\/span>, <\/span>\u5fd7\u6c34 \u967d\u4e00<\/span>, <\/span>\u4f50\u6cbb \u82f1\u90ce<\/span><\/span><\/span><\/span>
        \n\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u8133\u5185\u30bf\u30a6\u3092\u6a19\u7684\u3068\u3057\u305f\u653e\u5c04\u6027\u30e8\u30a6\u7d20\u6a19\u8b58\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30d4\u30ea\u30b8\u30f3\u8a98\u5c0e\u4f53\u306b\u95a2\u3059\u308b\u69cb\u9020\u6d3b\u6027\u76f8\u95a2\u7814\u7a76<\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c138\u5e74\u4f1a \uff08\u91d1\u6ca2)\u00a02018\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      17. \u798f\u4e95 \u8b19\u543e, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce<\/span><\/span><\/span><\/span>
        \n<\/span><\/span>\u30aa\u30ec\u30ad\u30b7\u30f3<\/span>1<\/span>\u53d7\u5bb9\u4f53\u9078\u629e\u7684\u306a<\/span>PET<\/span>\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898f<\/span>18<\/sup>F<\/span>\u6a19\u8b58\u30c6\u30c8\u30e9\u30d2\u30c9\u30ed\u30a4\u30bd\u30ad\u30ce\u30ea\u30f3\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span>
        \n<\/span><\/span>\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c138\u5e74\u4f1a \uff08\u91d1\u6ca2)\u00a02018\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span>
        \n<\/span><\/li>\n
      18. \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span>
        \n<\/span><\/span>\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306b\u3088\u308b\u30c8\u30e9\u30f3\u30b9\u30ec\u30fc\u30b7\u30e7\u30ca\u30eb\u30ea\u30b5\u30fc\u30c1(\u62db\u5f85\u8b1b\u6f14)<\/span><\/span><\/span><\/span><\/span>
        \n<\/span><\/span>\u7b2c16\u56deOMIC\u4e8b\u696d\u63a8\u9032\u30bb\u30df\u30ca\u30fc<\/span><\/span><\/span><\/span>\uff08\u5ca1\u5c71)\u00a02018\u5e742\u670823\u65e5<\/span><\/span><\/span><\/li>\n<\/ol>\n

        \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

        2018 (\u8ad6\u6587) Watanabe H, Yoshimura M, Sano K, Shimizu Y, Kaide S, Nakamoto Y, Togashi K, Ono M, Saji H. Character […]<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_crdt_document":"","footnotes":""},"class_list":["post-2868","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/comments?post=2868"}],"version-history":[{"count":1,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2868\/revisions"}],"predecessor-version":[{"id":2869,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2868\/revisions\/2869"}],"wp:attachment":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/media?parent=2868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}